Delivery Order SPE2DB20D1004-SPE2DB22FF6Y8
Award Date
5/25/22
Potential Completion Date
5/26/22
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,840.69, is for the delivery of RECTIV 0.4% ointment in 30 gram tubes. The contract is a Firm Fixed Price Delivery Order with a completion date of January 13, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $2,954.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RECTIV 0.4% OINTMENT 30GM, a medical product, through a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564885184 RECTIV 0.4% OINTMENT 30GM to the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with a ceiling value of $1,958.04 and an ultimate completion date of June 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a division of the global pharmaceutical company Amerisourcebergen Corporation, is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical with a firm fixed price of $1,707.85 and a completion date of March 1, 2024. The contract is for the supply of RECTIV 0.4% ointment in 30 gram packages. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of a pharmaceutical product, RECTIV 0.4% Ointment 30GM. The $3,705.96 contract has an ultimate completion date of August 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ06F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.77 firm-fixed-price delivery order is for the supply of "RECTIV 0.4% OINTMENT 30GM", a medical product. This award is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,137.00, is a Delivery Order with a Firm Fixed Price pricing type. It covers the procurement of a pharmaceutical product, "RECTIV 0.4% OINTMENT 30GM," with a completion date of December 9, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is a Delivery Order (SPE2DB20D1100|SPE2DB24FD9X1) valued at $1,831.65 for the supply of 4565921481 ! RECTIV 0.4% OINTMENT 30GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, on September 24, 2024, with an ultimate completion date of September 25, 2024. This appears to be a Firm Fixed Price contract for the delivery of pharmaceutical products. There is no set-aside designation...
This federal contract award, valued at $1,173.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of "RECTIV 0.4% OINTMENT 30GM", a medical product. The contract has a period of performance through July 15, 2024 and is a firm fixed-price arrangement. This award is not designated as a set-aside contract. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of RECTIV 0.4% ointment, a pharmaceutical product, with a ceiling value of $2,649.64 and a completion date of September 20, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation. AmerisourceBergen holds several indefinite delivery contracts (IDCs) with federal agencies,...